Share Purchase Warrants (Details 1) |
6 Months Ended |
|---|---|
|
Sep. 30, 2019
$ / shares
shares
| |
| Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
| Number of warrants outstanding | 4,300,000 |
| Exercise price 2.50 [Member] | |
| Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
| Number of warrants outstanding | 3,300,000 |
| Exercise price | $ / shares | $ 2.50 |
| Expiry date | Jul. 01, 2020 |
| Exercise price 1.00 [Member] | |
| Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
| Number of warrants outstanding | 1,000,000 |
| Exercise price | $ / shares | $ 1.00 |
| Expiry date | Nov. 23, 2019 |
| X | ||||||||||
- Definition Date the equity-based award expires, in CCYY-MM-DD format. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|